BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

NEOGENOMICS LABORATORIES

via MR. ALAN MERTZ

2nd Quarter (Apr 1 - June 30) · 2018Posted Jul 2, 2018Filing document ↗LDA record ↗

Income$36Kfee reported

Client

Name: NEOGENOMICS LABORATORIES
Description: Oncology diagnostic testing company
Location: Florida · United States of America

Registrant

Firm: MR. ALAN MERTZ
Description: Consulting LLC
Location: Naples, Florida, United States of America

Lobbying activities

1 issue

Health Issues
Diagnostic Innovation & Accountability Act (Draft bill, not introduced)
LobbyistsALAN MERTZ
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

NEOGENOMICS LABORATORIES — Lobbying — Receipts Report